about
Leukocyte Cell-Derived Chemotaxin-2: It's Role in Pathophysiology and Future in Clinical MedicineHypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disordersWNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathwaysClinical Outcome 3 Years After Autologous Chondrocyte Implantation Does Not Correlate With the Expression of a Predefined Gene Marker Set in Chondrocytes Prior to Implantation but Is Associated With Critical Signaling PathwaysA Qualitative Model of the Differentiation Network in Chondrocyte Maturation: A Holistic View of Chondrocyte Hypertrophy.Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6.Loss of spatial organization and destruction of the pericellular matrix in early osteoarthritis in vivo and in a novel in vitro methodology.Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto RicoiTRAQ-based proteomics reveals novel biomarkers of osteoarthritis.Cell signaling pathways related to pain receptors in the degenerated disk.Small molecule inhibitors of WNT/β-catenin signaling block IL-1β- and TNFα-induced cartilage degradation.Mechanical loading: bone remodeling and cartilage maintenance.Comparative proteomic analysis of hypertrophic chondrocytes in osteoarthritis.Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis.Effects of Wnt3A and mechanical load on cartilage chondrocyte homeostasisDual function of β-catenin in articular cartilage growth and degeneration at different stages of postnatal cartilage development.Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis.Protective role of frizzled-related protein B on matrix metalloproteinase induction in mouse chondrocytes.Network medicine analysis of chondrocyte proteins towards new treatments of osteoarthritis.Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.Effects of Qi-Fang-Xi-Bi-Granules on Cartilage Morphology and C/ebpα Promoter Methylation in Rats with Knee Osteoarthritis.
P2860
Q33891547-60DDC18C-6BC2-4C0F-8436-08A1FB27ECDFQ34346172-8321896A-03F5-423C-884B-B3FA0FE88DE0Q34918244-C03F5C62-C3D3-4228-8F94-1F6A1F9C0558Q36014016-AF058097-87F7-4211-A17F-10E183E397CEQ36118435-00DD70AC-F6B7-4BFA-9AFC-DEF4AAD92924Q36635388-266C3ACB-E458-4C02-BB8A-AC041F4DC3B5Q37004050-1FA98CC0-94CA-438E-8DF8-5DF6FD30B6F3Q37273672-8918A350-3072-4D96-A785-AB60961366C3Q37332087-68160303-0CF3-48C7-AE78-A6D858249B3EQ37376474-0832EFF9-8267-4AF1-80D4-8A55F0FF2FD8Q37690284-C602C9C0-2E6F-4FAE-815F-7A1129BFA227Q37920768-F1D57CDC-201A-4209-8BB0-61A5161CD6F1Q38463545-149A8C07-ECE8-4213-B91D-19DF4F73425CQ38861162-4B48CA31-11C2-427E-9D95-9A772F112B26Q39677719-4D6483E0-6E5D-4EFD-8F06-83CA9145B255Q41979369-7EC5B4D9-4850-4221-ABF8-9184BCEED93CQ42965984-93A2BDA8-F33D-4B58-8F91-617EAA17EE4AQ42996550-2F3CCB77-8169-45BE-B4CE-6E53644FAA66Q51123079-30B30A39-6403-4270-B9FA-D0F2928FBC6DQ54392392-F40CEAE2-B101-4AF1-8E6A-D021FDE917F0Q55069981-3F9A94D7-350F-4A78-B1AE-115683F3C9F4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta-catenin, cartilage, and osteoarthritis.
@en
Beta-catenin, cartilage, and osteoarthritis.
@nl
type
label
Beta-catenin, cartilage, and osteoarthritis.
@en
Beta-catenin, cartilage, and osteoarthritis.
@nl
prefLabel
Beta-catenin, cartilage, and osteoarthritis.
@en
Beta-catenin, cartilage, and osteoarthritis.
@nl
P2093
P2860
P1476
Beta-catenin, cartilage, and osteoarthritis.
@en
P2093
Michael J Zuscik
Qiuqian Wu
Randy N Rosier
Regis J O'Keefe
P2860
P304
P356
10.1111/J.1749-6632.2009.05212.X
P407
P577
2010-03-01T00:00:00Z